Cyclo Therapeutics’ TransportNPC™ Phase 3 clinical trial for Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is fully enrolled and results from the 48-week interim analysis are expected later this month NEWARK, N.J., June 11, 2025 (GLOBE NEWSWIRE) — Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT), today reported its financial results for the third quarter and first nine months of fiscal year 2025 ended April 30, 2025. “We are pleased to have completed our merger with Cyclo Therapeutics and look forward to reporting the topline data from the 48-week interim analysis of the pivotal Phase 3 TransportNPC™ study evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 anticipated later this month,” said Howard Jonas, Chief...

First quarter sales and operating income exceed expectations Reaffirms full year 2025 sales guidance REYNOLDSBURG, Ohio, June 11, 2025 (GLOBE NEWSWIRE) — Victoria’s Secret & Co. (“VS&Co” or the “Company”) (NYSE: VSCO) today reported financial results for the first quarter ended May 3, 2025. “I am proud of the team and their commitment to adapting and remaining flexible in this challenging and fast-changing environment. We focused on proactively managing the business ensuring we are remaining nimble and protecting investments in what matters most—the customer experience, brand health and product innovation. I am pleased with the strength the business demonstrated during the March and April timeframe, which included continued momentum in our powerhouse Beauty business, ongoing strength in PINK apparel, and newness in sport...

Grew ARR 30% year-over-year to $925 million Increased SaaS ARR 39% year-over-year to $574 million Expanded the number of customers with more than $1 million of ARR by 62% year-over-yearAUSTIN, Texas, June 11, 2025 (GLOBE NEWSWIRE) — SailPoint, Inc. (Nasdaq: SAIL), a leader in enterprise identity security, today announced financial results for its fiscal first quarter ended April 30, 2025. “We delivered another strong quarter, driven by continued expansion across our customer base and strong adoption among Fortune 500 and Forbes Global 2000 companies,” said Mark McClain, CEO and Founder, SailPoint. “Enterprises are turning to SailPoint to manage both human and digital identities at the scale and speed required to stay ahead. Our ability to deliver both breadth and depth of identity security—on a platform that’s AI and data-driven...

Sustained Momentum with a Third Year of Diversified Growth and Solid Financial Strength Fourth Quarter HighlightsOrganic growth of 16.1% year-over-year in Broadcast and Recurring Commercial Music Revenues; Revenues increased 14.8% to $96.0 million in the fourth quarter of 2025 from $83.7 million in the fourth quarter of 2024; Net income totaled $7.7 million, or $0.11 per share, in the fourth quarter of 2025 compared to a Net loss of $46.3 million, or $0.67 per share, in the same period in 2024; Adjusted EBITDA(1) grew 19.0% to $35.0 million in the fourth quarter of 2025 from $29.4 million in the fourth quarter of 2024. Adjusted EBITDA(1) by segment was $28.1 million, or 43.6% of revenues for Broadcasting and Commercial Music, $8.6 million or 27.3% of revenues for Radio, and $(1.7) million for Corporate; Adjusted Net income(1) improved...

Royalty-driven Model delivers Strong Margin Expansion and Cash Generation; Leadership Transition positions Company for Next Phase of Growth All dollar amounts are expressed in Canadian currency(1) Please refer to “non-IFRS and other financial performance measures” in this press release Fiscal 2025 HighlightsRecord total revenues of $42.8 million, up 8% vs. FY 2024 Record royalties of $11 million, up 27% vs. FY 2024 Adjusted EBITDA1 of $7.3 million, or 17% of total revenues, up 9 pts vs. FY 2024 Net profit of $3.9 million, up 254% year-over-year, or fully diluted EPS of $0.02 Cash flow from operating activities of $7.3 million Liquidity of approximately $16 million as of March 31, 2025Fourth Quarter HighlightsTotal revenues of $8.6 million, down 15% vs. Q4 2024 Royalties of $2.2 million, up 5% year-over-year Adjusted EBITDA...

BEIJING, June 11, 2025 (GLOBE NEWSWIRE) — 17 Education & Technology Group Inc. (NASDAQ: YQ) (“17EdTech” or the “Company”), a leading education technology company in China, today announced its unaudited financial results for the first quarter of 2025. First Quarter 2025 Highlights1Net revenues were RMB21.7 million (US$3.0 million), compared with net revenues of RMB25.5 million in the first quarter of 2024. Gross margin was 36.2%, compared with 38.4% in the first quarter of 2024. Net loss was RMB30.9 million (US$4.3 million), compared with net loss of RMB56.1 million in the first quarter of 2024. Net loss as a percentage of net revenues was negative 142.8% in the first quarter of 2025, compared with negative 219.9% in the first quarter of 2024. Adjusted net loss2 (non-GAAP), which excluded share-based compensation expenses...

ATHENS and NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) — Heidmar Maritime Holdings Corp. (the “Company” or “Heidmar”) (NASDAQ: HMR) today reported its results for the quarter ended March 31, 2025. First Quarter 2025 HighlightsTotal net revenues of $5.8 million.Net loss attributable to shareholders of $6.0 million or $0.1 per shareAdjusted net income(1)attributable to shareholders for the quarter of $875,194 or $0.02 income per share, excluding non-cash expense of $3.9 million relating to the fair value of the earnout shares that will be issued to certain of the Company’s shareholders upon the satisfaction of certain conditions set forth in the business combination agreement with MGO Global Inc, the non-cash bonus of stock based compensation of $1.5 million and the amortization of Heidmar’s 2025...

SAN FRANCISCO, June 10, 2025 (GLOBE NEWSWIRE) — Stitch Fix, Inc. (NASDAQ: SFIX), the leading online personal styling service, today announced its financial results for the third quarter of fiscal year 2025, ended May 3, 2025. “Stitch Fix delivered strong third quarter results, marked by our overall return to year-over-year revenue growth,” said Matt Baer, CEO, Stitch Fix. “Our performance, which exceeded expectations, is the direct result of the strength of the Stitch Fix value proposition and the team’s disciplined execution of our strategy. Now in the growth phase of our transformation, we are focused on cementing our role as the retailer of choice for apparel and accessories by consistently delivering the most client-centric and personalized shopping experience.” Third Quarter Fiscal 2025 Key Metrics and Financial HighlightsNet...

DALLAS, June 10, 2025 (GLOBE NEWSWIRE) — Dave & Buster’s Entertainment, Inc., (NASDAQ: PLAY), (“Dave & Buster’s” or “the Company”), an owner and operator of entertainment and dining venues, today announced financial results for its first quarter of fiscal 2025 ended May 6, 2025. First Quarter 2025 Financial SummaryFirst quarter revenue of $567.7 million decreased 3.5% from the first quarter of fiscal 2024. Comparable store sales decreased 8.3% compared to the same calendar period in fiscal 2024. Net income totaled $21.7 million, or $0.62 per diluted share, compared with net income of $41.4 million, or $0.99 per diluted share in the first quarter of fiscal 2024. Adjusted Net income totaled $26.7 million, or $0.76 per diluted share, compared with an Adjusted Net income of $46.4 million, or $1.12 per diluted...

Safe Group announces FDA 510(k) clearance for SpineUp’s Frida solution Fleurieux-sur-l’Arbresle – France – June 5, 2025 at 6 p.m. Safe Group, a leading player in the field of medical devices for spine surgery, is pleased to announce that Frida, the innovative cervical plate developed by SpineUp, has received 510(k) clearance from the Food and Drug Administration (FDA). This clearance marks a crucial step in SpineUp’s expansion into the North American market, and testifies to its ongoing commitment to providing cutting-edge medical solutions. Frida is a new-generation cervical plate offering high adaptability with a multiplicity of plate and screw sizes. Thanks to this technology, healthcare professionals will be able to offer more personalized treatments, tailored to the specific needs of surgeons and their patients. FDA...